NALTREXONE PLUS KETAMINE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER

被引:0
|
作者
Yoon, G. [1 ]
Ralevski, E. [1 ]
Arias, A. J. [1 ]
Limoncelli, D. [1 ]
Newcomb, J. [1 ]
Levy, L. [1 ]
Jane, J. S. [1 ]
Krystal, J. H. [1 ]
Petrakis, I. L. [1 ]
机构
[1] Yale Univ, Dept Psychiat, VA Connecticut Healthcare Syst, West Haven, CT 06516 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
869
引用
收藏
页码:236A / 236A
页数:1
相关论文
共 50 条
  • [21] Evidence for the use of vilazodone in the treatment of major depressive disorder
    Reinhold, Jennifer A.
    Mandos, Laura A.
    Lohoff, Falk W.
    Rickels, Karl
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2215 - 2224
  • [22] Use of Risperidone as Augmentation Treatment for Major Depressive Disorder
    Owenby, Ryan K.
    Brown, Lindsey T.
    Brown, Jamie N.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (01) : 95 - 100
  • [23] Treatment for major depressive disorder
    Zhang, X.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 : 81 - 81
  • [24] Nalmefene in alcohol-related disorder and major depressive disorder
    Garcia de Diego, B. O. Plasencia
    Romero Guillena, S. L.
    Gonzalez Moreno, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S601 - S601
  • [25] Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives
    Shin, Cheolmin
    Kim, Yong-Ku
    PSYCHIATRY INVESTIGATION, 2020, 17 (03) : 181 - 192
  • [26] Naltrexone in the treatment of binge eating disorder in a patient with severe alcohol use disorder: a case report
    Leroy, Arnaud
    Carton, Louise
    Gomajee, Harry
    Bordet, Regis
    Cottencin, Olivier
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2017, 43 (05): : 618 - 620
  • [27] EXAMINING THE INFLUENCE OF NICOTINE USE ON NALTREXONE RESPONSE AS TREATMENT FOR ALCOHOL USE DISORDER
    Hoffman, M.
    Latham, P. K.
    Voronin, K. E.
    Randall, P. K.
    Book, S. W.
    Schacht, J. P.
    Anton, R. F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 64A - 64A
  • [28] ROLE OF COPPER AND KETAMINE IN MAJOR DEPRESSIVE DISORDER - AN UPDATE
    Slupski, Jakub
    Slupska, Anita
    Szalach, Lukasz P.
    Wlodarczyk, Adam
    Gorska, Natalia
    Szarmach, Joanna
    Jakuszkowiak-Wojten, Katarzyna
    Galuszko-Wegielnik, Maria
    Wilkowska, Alina
    Wiglusz, Mariusz S.
    Cubala, Wieslaw Jerzy
    PSYCHIATRIA DANUBINA, 2019, 31 : S520 - S523
  • [29] The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
    Nugent, Allison C.
    Ballard, Elizabeth D.
    Gilbert, Jessica R.
    Tewarie, Prejaas K.
    Brookes, Matthew J.
    Zarate, Carlos A., Jr.
    FRONTIERS IN PSYCHIATRY, 2020, 11
  • [30] Could ketamine be the answer to treating treatment-resistant major depressive disorder?
    Abdullah Mohammed Ramadan
    Islam Ahmed Mansour
    上海精神医学, 2020, (05) : 296 - 300